Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · see citing works

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works

Prediction of coronary heart disease using risk factor categories

Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · see citing works

Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men: Prospective Results From the Que´bec Cardiovascular Study

Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077 · see citing works

Metabolic origins and clinical significance of LDL heterogeneity

Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896 · see citing works

Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · see citing works

EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.

Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780 · see citing works

Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

Cui, Y. A., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., LANGENBERG, P. W., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 657 · see citing works

Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance

Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A. C., Pugh, K. B., Jenkins, A. J., Klein, R. L., & Liao, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.453 · Cited by 606 · see citing works

Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial

Otvos, J. D., Collins, D. E., Freedman, D. S., SHALAUROVA, I. Y., Schaefer, E. J., McNamara, J. R., Bloomfield, H. E., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.565135 · Cited by 542 · see citing works

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men

Pischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514 · see citing works

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Barter, P. J., Ballantyne, C. M., Carmena, R., Cabezas, M. C., Chapman, M. J., Couture, P., Graaf, J. D., Durrington, P. N., Færgeman, O., Frohlich, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 463 · see citing works

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

Sniderman, A. D., Furberg, C. D., KEECH, A. C., van Lennep, J. R., Frohlich, J., Jungner, I., & Walldius, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12663-3 · Cited by 457 · see citing works

Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women

Blake, G. J., Otvos, J. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000033222.75187.b9 · Cited by 409 · see citing works

LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)

Mora, S., Szklo, M., Otvos, J. D., Greenland, P., Psaty, B. M., Goff, D. C., O’Leary, D. H., Saad, M. F., Tsai, M. Y., & Sharrett, A. R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.007 · Cited by 380 · see citing works

Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.

Otvos, J. D. (2002) · PubMed · Cited by 347 · see citing works

Increased Small Low-Density Lipoprotein Particle Number

Kathiresan, S., Otvos, J. D., SULLIVAN, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W. F., D’Agostino, R. B., Vasan, R. S., & Robins, S. J. (2005) · Circulation · doi:10.1161/circulationaha.105.567107 · Cited by 317 · see citing works

Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study

Kuller, L. H., Arnold, A. M., Tracy, R. P., Otvos, J. D., Burke, G. L., Psaty, B. M., Siscovick, D. S., Freedman, D. S., & Kronmal, R. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022015.97341.3a · Cited by 310 · see citing works

Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study

Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., SHALAUROVA, I. Y., Cupples, L. A., Parise, H., D’Agostino, R. B., Wilson, P. W. F., & Schaefer, E. J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032763 · Cited by 304 · see citing works

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial

Rosenson, R. S., Otvos, J. D., & Freedman, D. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02427-x · Cited by 293 · see citing works

EPIC-Norfolk: Study design and characteristics of the cohort

Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · UEA Digital Repository (University of East Anglia) · Cited by 261 · see citing works

Measurement issues related to lipoprotein heterogeneity

Otvos, J. D., Jeyarajah, E. J., & Cromwell, W. C. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02632-2 · Cited by 259 · see citing works

Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal

Sacks, F. M., & Campos, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030636 · Cited by 241 · see citing works

Low-density lipoprotein particle number and risk for cardiovascular disease

Cromwell, W. C., & Otvos, J. D. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0050-5 · Cited by 198 · see citing works

Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins.

Rumsey, S. C., Galeano, N. F., Arad, Y., & Deckelbaum, R. J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41409-9 · Cited by 136 · see citing works

Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk Prospective Population study

Boekholdt, S. M., Peters, R. J. G., Day, N., Luben, R., Bingham, S. A., Wareham, N. J., Hack, C. E., Reitsma, P. H., & Khaw, K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.010 · Cited by 84 · see citing works

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,968 · see citing works

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,322 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716 · see citing works

Lipoprotein Management in Patients With Cardiometabolic Risk

Brunzell, J. D., Davidson, M. H., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Diabetes Care · doi:10.2337/dc08-9018 · Cited by 710 · see citing works

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

Mazzone, T., Chait, A., & Plutzky, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60768-0 · Cited by 545 · see citing works

Lipoprotein Management in Patients With Cardiometabolic Risk

Brunzell, J. D., Davidson, M. H., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.034 · Cited by 523 · see citing works

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.

Mora, S., Otvos, J. D., Rifai, N., Rosenson, R. S., Buring, J. E., & Ridker, P. M. (2009) · Circulation · doi:10.1161/circulationaha.108.816181 · Cited by 490 · see citing works

Clinical implications of discordance between low-density lipoprotein cholesterol and particle number

Otvos, J. D., Mora, S., SHALAUROVA, I. Y., Greenland, P., Mackey, R. H., & Goff, D. C. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.02.001 · Cited by 385 · see citing works

Beyond Low-Density Lipoprotein Cholesterol

Arsenault, B. J., Rana, J. S., Stroes, E. S. G., Després, J.-P., Shah, P. K., Kastelein, J. J. P., Wareham, N. J., Boekholdt, S. M., & Khaw, K.-T. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.057 · Cited by 342 · see citing works

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

Contois, J. H., McConnell, J. P., Sethi, A. A., Csako, G., Devaraj, S., Hoefner, D. M., & Warnick, G. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118356 · Cited by 326 · see citing works

Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose

DeFronzo, R. A., & Abdul‐Ghani, M. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.013 · Cited by 318 · see citing works

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works

Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women

Wu, T., Gao, Y., Zheng, Y., Ma, Y., & Xie, X. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0828-z · Cited by 281 · see citing works

Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score

Tzoulaki, I. (2009) · JAMA · doi:10.1001/jama.2009.1757 · Cited by 276 · see citing works

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Langlois, M. R., Chapman, M. J., Cobbaert, C., Mora, S., Remaley, A. T., Ros, E., Watts, G. F., Borén, J., Baum, H., Bruckert, E., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287037 · Cited by 260 · see citing works

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey

KONES, R. J. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 257 · see citing works

Lipid parameters for measuring risk of cardiovascular disease

Arsenault, B. J., Boekholdt, S. M., & Kastelein, J. J. P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.223 · Cited by 228 · see citing works

Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study

Parish, S., Offer, A. R., Clarke, R., Hopewell, J. C., Hill, M., Otvos, J. D., Armitage, J., & Collins, R. (2012) · Circulation · doi:10.1161/circulationaha.111.073684 · Cited by 211 · see citing works

New Automated Assay of Small Dense Low-Density Lipoprotein Cholesterol Identifies Risk of Coronary Heart Disease

Tsai, M. Y., Steffen, B. T., Guan, W., McClelland, R. L., Warnick, R., McConnell, J. P., Hoefner, D. M., & Remaley, A. T. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302401 · Cited by 183 · see citing works

NMR measurement of LDL particle number using the Vantera® Clinical Analyzer

Matyus, S. P., Braun, P. J., Wolak, J. E., Jeyarajah, E. J., SHALAUROVA, I. Y., Xu, Y., Warner, S. M., Clement, T. S., Connelly, M. A., & Fischer, T. J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.07.015 · Cited by 169 · see citing works

Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.

Ip, S., Lichtenstein, A. H., Chung, M., Lau, J., & Balk, E. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-7-200904070-00007 · Cited by 163 · see citing works

Associations between smoking, components of metabolic syndrome and lipoprotein particle size

Slagter, S. N., van Vliet‐Ostaptchouk, J. V., Vonk, J. M., Boezen, H. M., Dullaart, R. P. F., Kobold, A. C. M., Feskens, E. J. M., van Beek, A. P., van der Klauw, M. M., & Wolffenbuttel, B. H. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-195 · Cited by 151 · see citing works

Ezetimibe: cholesterol lowering and beyond

Bays, H. E., Neff, D., Tomassini, J. E., & Tershakovec, A. M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.4.447 · Cited by 145 · see citing works

Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence

Aday, A. W., Lawler, P. R., Cook, N. R., Ridker, P. M., Mora, S., & Pradhan, A. D. (2018) · Circulation · doi:10.1161/circulationaha.118.035432 · Cited by 140 · see citing works

Beyond Low-Density Lipoprotein Cholesterol

Mudd, J. O., Borlaug, B. A., Johnston, P. V., Kral, B. G., Rouf, R., Blumenthal, R. S., & Kwiterovich, P. O. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.045 · Cited by 136 · see citing works

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

Semb, A. G., Kvien, T. K., AASTVEIT, A. H., Jungner, I., Pedersen, T. R., Walldius, G., & Holme, I. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126128 · Cited by 136 · see citing works

Triglycerides and risk for coronary artery disease

McBride, P. E. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0060-9 · Cited by 116 · see citing works

Low-density lipoprotein particles in atherosclerosis

Qiao, Y.-N., Zou, Y., & Guo, S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.931931 · Cited by 114 · see citing works

Changes in Emerging Cardiac Biomarkers After an Intensive Lifestyle Intervention

Chainani‐Wu, N., Weidner, G., Purnell, D. M., Frenda, S. J., Merritt-Worden, T. A., Pischke, C. R., Campo, R., Kemp, C., Kersh, E. S., & Ornish, D. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.077 · Cited by 106 · see citing works

Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics

Ala‐Korpela, M. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.006 · Cited by 104 · see citing works

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

Sawada, T., Tsubata, H., Hashimoto, N., Takabe, M., Miyata, T., Aoki, K., Yamashita, S., Oishi, S., Osue, T., Yokoi, K., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0437-y · Cited by 97 · see citing works

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

on behalf of the FIELD study investigators, Taskinen, M.-R., Barter, P. J., Ehnholm, C., Sullivan, D. R., Mann, K., Simes, J., Best, J. D., Hamwood, S., & Keech, A. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1806-9 · Cited by 94 · see citing works

Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease

Williams, P. T., Zhao, X.-Q., Marcovina, S. M., Otvos, J. D., Brown, B. G., & Krauss, R. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.034 · Cited by 94 · see citing works

Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Superko, H. R., & Gadesam, R. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0059-2 · Cited by 91 · see citing works

Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs

Harisa, G. I., & Alanazi, F. K. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.12.015 · Cited by 91 · see citing works

Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes

Adaikalakoteswari, A., Jayashri, R., Sukumar, N., Venkataraman, H., Pradeepa, R., Gokulakrishnan, K., Anjana, R. M., McTernan, P. G., Tripathi, G., Patel, V., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0129-4 · Cited by 92 · see citing works

Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use

Mora, S. (2009) · Circulation · doi:10.1161/circulationaha.108.819359 · Cited by 89 · see citing works

Lipid metabolism in long-lived families: the Leiden Longevity Study

On behalf of the project group and the Leiden Longevity Study (LLS) Group, Vaarhorst, A. A. M., Beekman, M., Suchiman, H. E. D., van Heemst, D., Houwing‐Duistermaat, J. J., Westendorp, R. G. J., Slagboom, P. E., & Heijmans, B. T. (2010) · AGE · doi:10.1007/s11357-010-9172-6 · Cited by 89 · see citing works

Elevated Small Dense Low-Density Lipoprotein Cholesterol as a Predictor for Future Cardiovascular Events in Patients with Stable Coronary Artery Disease

Nishikura, T., Koba, S., Yokota, Y., Hirano, T., Tsunoda, F., Shoji, M., Hamazaki, Y., Suzuki, H., Itoh, Y., Katagiri, T., et al. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.23465 · Cited by 88 · see citing works

Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia

Maki, K. C., Bays, H. E., Dicklin, M. R., Johnson, S. L., & Shabbout, M. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.09.001 · Cited by 81 · see citing works

A metabolomic profile is associated with the risk of incident coronary heart disease

Vaarhorst, A. A. M., Verhoeven, A., Weller, C. M., Böhringer, S., Göraler, S., Meissner, A., Deelder, A. M., Henneman, P., Gorgels, A. P. M., van den Brandt, P. A., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.01.019 · Cited by 82 · see citing works

A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.

de Graaf, J., Couture, P., & Sniderman, A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0982 · Cited by 80 · see citing works

Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk

van Capelleveen, J. C., Moens, S. J. B., Yang, X., Kastelein, J. J. P., Wareham, N. J., Zwinderman, A. H., Stroes, E. S. G., Witztum, J. L., Hovingh, G. K., Khaw, K., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309007 · Cited by 71 · see citing works

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

Davidson, M. H., Maki, K. C., Bays, H., Carter, R., & Ballantyne, C. M. (2009) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2009.08.001 · Cited by 71 · see citing works

LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study

Pichler, G., Amigó, N., Téllez-Plaza, M., Pardo-Cea, M. Á., Dominguez-Lucas, A., Marrachelli, V. G., Monleón, D., Martı́n-Escudero, J. C., Ascaso, J. F., Chaves, F. J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.128 · Cited by 67 · see citing works

Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age)

Goliasch, G., Oravec, S., Blessberger, H., Dostal, E., Hoke, M., Wojta, J., Schillinger, M., Huber, K., Maurer, G., & Wiesbauer, F. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02629.x · Cited by 68 · see citing works

Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy

Airan‐Javia, S., Wolf, R. L., Wolfe, M. L., Tadesse, M. G., Mohler, E. R., & Reilly, M. P. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.01.001 · Cited by 62 · see citing works

Polyphenol Rich Olive Oils Improve Lipoprotein Particle Atherogenic Ratios and Subclasses Profile: A Randomized, Crossover, Controlled Trial

Fernández‐Castillejo, S., Valls, R., Castañer, O., Rubió, L., Catalán, Ú., Pedret, A., Macià, A., Sampson, M. L., Covas, M., Fitó, M., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201501068 · Cited by 61 · see citing works

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites

Martin, S. S., Qasim, A. N., Mehta, N. N., Wolfe, M., Terembula, K., Schwartz, S., Iqbal, N., Schutta, M., Bagheri, R., & Reilly, M. P. (2009) · Diabetes · doi:10.2337/db08-1794 · Cited by 60 · see citing works

Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: Does size matter?

Phillips, C. M., & Perry, I. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.040 · Cited by 56 · see citing works

LDL subfractions are associated with incident cardiovascular disease in the Malmö Prevention Project Study

Shiffman, D., Louie, J. Z., Caulfield, M. P., Nilsson, P. M., Devlin, J. J., & Melander, O. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.07.003 · Cited by 57 · see citing works

Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis

Pérez‐Martínez, P., Alcala-Diaz, J. F., Delgado‐Lista, J., García‐Ríos, A., Gómez-Delgado, F., Marín-Hinojosa, C., Rodríguez-Cantalejo, F., Delgado‐Casado, N., Pérez-Caballero, A. I., Fuentes, F. J., et al. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12339 · Cited by 55 · see citing works

Combined dyslipidemia in childhood

Kavey, R.-E. W. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.06.008 · Cited by 55 · see citing works

Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients

Nicholls, S. J., Ruotolo, G., Brewer, H. B., Wang, M.-D., Liu, L., Willey, M. B., Deeg, M. A., Krueger, K. A., & Nissen, S. E. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.11.014 · Cited by 53 · see citing works

Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes

Ratner, R. E., Parikh, S. J., & Tou, C. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.042 · Cited by 52 · see citing works

Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk

Rosenson, R. S., Davidson, M. H., & Pourfarzib, R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.03.038 · Cited by 51 · see citing works

Modified ketogenic diets in adults with refractory epilepsy: Efficacious improvements in seizure frequency, seizure severity, and quality of life

Roehl, K., Falco-Walter, J. J., Ouyang, B., & Balabanov, A. J. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.12.010 · Cited by 51 · see citing works

NMR-determined lipoprotein subclass profile predicts type 2 diabetes

Hodge, A. M., Jenkins, A. J., English, D. R., O’Dea, K., & Giles, G. G. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.007 · Cited by 50 · see citing works

Associations between non-traditional lipid measures and risk for type 2 diabetes mellitus in a Chinese community population: a cross-sectional study

Song, Q., Liu, X., Wang, A., Wang, Y., Zhou, Y., Zhou, W., & Wang, X. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0239-y · Cited by 47 · see citing works

Low-density lipoprotein particle diameter and mortality: the Ludwigshafen Risk and Cardiovascular Health Study

Grammer, T. B., Kleber, M. E., März, W., Silbernagel, G., Siekmeier, R., Wieland, H., Pilz, S., Tomaschitz, A., Köenig, W., & Scharnagl, H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu055 · Cited by 46 · see citing works

Correlation between small dense low-density lipoprotein cholesterol and carotid artery intima-media thickness in a healthy Chinese population

Shen, H., Xu, L., Lu, J., Hao, T., Ma, C., Yang, H., Lu, Z., Gu, Y., Zhu, T.-H., & Shen, G. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0143-x · Cited by 45 · see citing works

Systematic Review: Evaluating the Effect of Lipid-Lowering Therapy on Lipoprotein and Lipid Values

Rosenson, R. S., & Underberg, J. A. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6477-6 · Cited by 45 · see citing works

Small dense LDL particles - a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study

Toft‐Petersen, A. P., Tilsted, H. H., Aarøe, J., Rasmussen, K., Christensen, T., Griffin, B. A., Aardestrup, I. V., Andreasen, A., & Schmidt, E. B. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-21 · Cited by 45 · see citing works

Statins and almonds to lower lipoproteins (the STALL Study)

Ruisinger, J. F., Gibson, C., Backes, J. M., SMITH, B. K., Sullivan, D. K., Moriarty, P. M., & Kris‐Etherton, P. M. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.10.001 · Cited by 45 · see citing works

Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia

Amor, A. J., Pinyol, M., Solà, E., Catalán, M., Cofán, M., Herreras, Z., Amigó, N., Gilabert, R., Sala‐Vila, A., Ros, E., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.02.001 · Cited by 45 · see citing works

The lipoprotein subfraction profile: heritability and identification of quantitative trait loci

Kaess, B. M., Fischer, M., Baessler, A., Stark, K. J., Huber, F., Kremer, W., Kalbitzer, H. R., Schunkert, H., Riegger, G. A. J., & Hengstenberg, C. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700338-jlr200 · Cited by 45 · see citing works

Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease

Krychtiuk, K. A., Kastl, S., Pfaffenberger, S., Lenz, M. W., Hofbauer, S. L., Wonnerth, A., Koller, L., Katsaros, K. M., Pongratz, T., Goliasch, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123367 · Cited by 44 · see citing works

Cardiovascular Benefits of Phenol‐Enriched Virgin Olive Oils: New Insights from the Virgin Olive Oil and HDL Functionality (VOHF) Study

Pedret, A., Fernández‐Castillejo, S., Valls, R. M., Catalán, Ú., Rubió, L., Romeu, M., Macià, A., Hazas, M. L. D. L., Farràs, M., Giralt, M., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800456 · Cited by 44 · see citing works

Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins

Lerman, R. H., Minich, D. M., Darland, G. K., Lamb, J. J., Chang, J., Hsi, A., Bland, J. S., & Tripp, M. L. (2009) · Journal of clinical lipidology · doi:10.1016/j.jacl.2009.11.002 · Cited by 43 · see citing works

Utility of non‐high‐density lipoprotein cholesterol in assessing incident type 2 diabetes risk

Ley, S. H., Harris, S. B., Connelly, P. W., Mamakeesick, M., Gittelsohn, J., Wolever, T. M. S., Hegele, R. A., Zinman, B., & Hanley, A. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01607.x · Cited by 43 · see citing works

Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus—Brief Report

Apro, J., Tietge, U. J. F., Dikkers, A., Parini, P., Angelin, B., & Rudling, M. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307385 · Cited by 43 · see citing works

Discordance between non-HDL-cholesterol and LDL-particle measurements: Results from the Multi-Ethnic Study of Atherosclerosis

deGoma, E. M., Davis, M. D., Dunbar, R. L., Mohler, E. R., Greenland, P., & French, B. C. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.012 · Cited by 43 · see citing works

Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden

Zhou, Z., Ong, K. L., Whelton, S. P., Allison, M., Curtis, A. J., Blaha, M. J., Breslin, M. C., Tonkin, A. M., Magnussen, C. G., Budoff, M. J., et al. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.03.025 · Cited by 42 · see citing works

Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women

Bendžala, M., Sabaka, P., Čaprnda, M., Komorníková, A., Bisahova, M., Baneszova, R., Petrovič, D., Prosecký, R., Rodrigo, L., Kružliak, P., et al. (2017) · Wiener klinische Wochenschrift · doi:10.1007/s00508-017-1264-1 · Cited by 42 · see citing works

An NMR-Based Metabolomic Approach to Investigate the Effects of Supplementation with Glutamic Acid in Piglets Challenged with Deoxynivalenol

Wu, M., Xiao, H., Ren, W., Yin, J., Hu, J., Duan, J., Liu, G., Tan, B., Xiong, X., Oso, A. O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113687 · Cited by 41 · see citing works

Low-density lipoprotein and apolipoprotein B: Clinical use in patients with coronary heart disease

Cromwell, W. C., & Barringer, T. A. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0067-z · Cited by 41 · see citing works

Lipoprotein particle number and size predict vascular structure and function better than traditional lipids in adolescents and young adults

Urbina, E. M., McCoy, C. E., Gao, Z., Khoury, P. R., SHAH, A. S., Dolan, L. M., & Kimball, T. R. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.05.011 · Cited by 41 · see citing works

Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia

Jarauta, E., Mateo‐Gállego, R., Gilabert, R., Plana, N., Junyent, M., de Groot, E., Cenarro, A., Masana, L., Ros, E., & Civeira, F. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.011 · Cited by 40 · see citing works

Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France

Bruckert, É., Kalmykova, O., Bittar, R., Carreau, V., Béliard, S., Saheb, S., Rosenbaum, D. H., Bonnefont‐Rousselot, D., Thomas, D., Emery, C., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.015 · Cited by 40 · see citing works

A double‐blind, placebo‐controlled trial of rosiglitazone for clozapine‐induced glucose metabolism impairment in patients with Schizophrenia

Henderson, D. C., Fan, X., Sharma, B., Copeland, P. M., Borba, C. P. C., Boxill, R., Freudenreich, O., Cather, C., Evins, A. E., & GOFF, D. C. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01325.x · Cited by 39 · see citing works

Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein

Mintzer, S., Skidmore, C. T., Rankin, S. J., Chervoneva, I., Pequinot, E., Capuzzi, D. M., & Sperling, M. R. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.10.001 · Cited by 38 · see citing works

Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy

van Bochove, K., van Schalkwijk, D. B., Parnell, L. D., Lai, C., Ordovás, J. M., de Graaf, A. A., van Ommen, B., & Arnett, D. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038072 · Cited by 38 · see citing works

Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile

Kaneva, A. M., Потолицына, Н. Н., & Bojko, E. R. (2016) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2016.1195411 · Cited by 37 · see citing works

Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study

Annuzzi, G., Rivellese, A. A., Wang, H., Patti, L., Vaccaro, O., Riccardi, G., Ebbesson, S. O. E., Comuzzie, A. G., Umans, J. G., & Howard, B. V. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.023887 · Cited by 35 · see citing works

Use of Lipoprotein Particle Measures for Assessing Coronary Heart Disease Risk Post-American Heart Association/American College of Cardiology Guidelines

Steffen, B. T., Guan, W., Remaley, A. T., Paramsothy, P., Heckbert, S. R., McClelland, R. L., Greenland, P., Michos, E. D., & Tsai, M. Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304349 · Cited by 35 · see citing works

The effects of fat consumption on low-density lipoprotein particle size in healthy individuals: a narrative review

Froyen, E. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01501-0 · Cited by 35 · see citing works

Association betweentrans-fatty acids in erythrocytes and pro-atherogenic lipid profiles among Canadian Inuit of Nunavik: possible influences of sex and age

Counil, É., Julien, P., Lamarche, B., Château‐Degat, M., Ferland, A., & Dewailly, É. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509297182 · Cited by 34 · see citing works

Protective effects of Spirulina on the liver function and hyperlipidemia of rats and human

El-Sheekh, M. M., Hamad, S. M., & Gomaa, M. (2014) · Brazilian Archives of Biology and Technology · doi:10.1590/s1516-89132014000100012 · Cited by 34 · see citing works

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target

Hoenig, M. R. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.143 · Cited by 33 · see citing works

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins

Sakamoto, K., Kawamura, M., Kohro, T., Omura, M., Watanabe, T., Ashidate, K., Horiuchi, T., Hara, H., Sekine, N., Chin, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138332 · Cited by 32 · see citing works

Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: Do novel lipid parameters offer an advantage?

Manickam, P., Rathod, A. D., Panaich, S., Hari, P., Veeranna, V., Badheka, A., Jacob, S., & Afonso, L. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.12.001 · Cited by 31 · see citing works

Lipid assessment, metabolic syndrome and coronary heart disease risk

Arsenault, B. J., Després, J., Stroes, E. S. G., Wareham, N. J., Kastelein, J. J. P., Khaw, K., & Boekholdt, S. M. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02357.x · Cited by 31 · see citing works

Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease

Davidson, W. S., Heink, A., Sexmith, H., Dolan, L. M., Gordon, S. M., Otvos, J. D., Melchior, J., Elder, D. A., Khoury, J. C., Geh, E. N., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m078667 · Cited by 30 · see citing works

The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates

Rizzo, M., & Berneis, K. K. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x187892 · Cited by 30 · see citing works

Comparison common equations for LDL-C calculation with direct assay and developing a novel formula in Iranian children and adolescents: the CASPIAN V study

Molavi, F., Namazi, N., Asadi, M., Sanjari, M., Motlagh, M. E., Shafiee, G., Qorbani, M., Heshmat, R., & Kelishadi, R. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01306-7 · Cited by 29 · see citing works

Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy

Decewicz, D. J., Neatrour, D. M., Burke, A., Haberkorn, M. J., Patney, H. L., Vernalis, M., & Ellsworth, D. L. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-26 · Cited by 29 · see citing works

Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?

Rizzo, M., Berneis, K., Koulouris, S., Pastromas, S. C., Rini, G. B., Sakellariou, D., & Manolis, A. S. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02378.x · Cited by 29 · see citing works

Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy

Ford, M. A., McConnell, J. P., Lavi, S., Rihal, C. S., Prasad, A., Sandhu, G. S., Hartman, S. J., Lerman, L. O., & Lerman, A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.039 · Cited by 29 · see citing works

Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants

Steffen, B. T., Guan, W., Remaley, A. T., Stein, J. H., Tattersall, M. C., Kaufman, J. D., & Tsai, M. Y. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.07.001 · Cited by 28 · see citing works

Mo-W7:7 Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction

Luca', F., Raffa, S., Crisafulli, A., Saporito, F., Micari, A., Altavilla, D., Sardella, A., Passaniti, M., Arrigo, F., & Squadrito, F. (2006) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(06)80068-1

Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · see citing works

LDL particle size was smaller in CAD, but other lipid parameters were stronger predictors of CAD

Meissner, M. D., & Meissner, M. D. (1997) · ACP Journal Club · doi:10.7326/acpjc-1997-126-2-048

LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management

Cromwell, W. C., Otvos, J. D., Keyes, M. J., Pencina, M. J., SULLIVAN, L. M., Vasan, R. S., Wilson, P. W. F., & D’Agostino, R. B. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.10.001 · Cited by 428 · see citing works

Low density lipoprotein particle size and coronary artery disease. Arterioscler. Thromb

Campos, H., Genest, J. J., Blijlevens, E., McNamara, J. R., Jenner, J. L., Ordovas, J. M., Wilson, P. W. F., & Schaefer, E. J. (1992)